FDA to review effectiveness of abuse deterrent opioid drugs
June 14, 2017Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid, opioid crisis
FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …
Genetic test reveals at-risk men for testicular cancer
June 14, 2017Research and Development ICR, Movember Foundation, testicular cancer
Research emerging from the Institute of Cancer Research has revealed the men most statistically at-risk of developing testicular cancer. The …
BMS vet joins Kleo Therapeutics as CEO
June 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Kleo Pharmaceutical
Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …
MSD forced to pause enrolment after Keytruda deaths
June 13, 2017Manufacturing and Production, Research and Development
MSD has been hit by a major surprise after an independent monitoring committee raised a warning after an imbalance in …
Prescription costs vary wildly between high-income countries
June 13, 2017Manufacturing and Production, Sales and Marketing medicine, prescription, prescription cost
A study originating out of Canada has laid bare the difference in cost of primary care prescription drugs between different …
Sun Pharma rises again with FDA cholesterol drug approval
June 13, 2017Manufacturing and Production Sun Pharma
Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …
FDA approves BioMarin’s Irish facility
June 13, 2017Manufacturing and Production BioMarin, Ireland, cork, vimizin
The FDA has approved BioMarin’s bulk biologic manufacturing plant, based in Cork, Ireland. The facility will manufacture an ingredient of …
SMC reverses decision on Opdivo for kidney cancer
June 12, 2017Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, SMC, opdivo
The Scottish Medicines Consortium (SMC) has performed a U-turn on its decision regarding Opdivo (nivolumab), and will now allow patients …
European Medicines Agency: Staying consistent in a turbulent time
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit
With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …
FlyPharma Conference 2017 – “Collaboration is the key”
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FlyPharma conference, PHARMA SUPPLY CHAIN, flypharma, supply chain
As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …
Type 2 diabetes directly linked to BMI
June 12, 2017Research and Development, Sales and Marketing diabetes, type 2 diabetes
Research emerging from the American Diabetes Association’s meeting in San Diego has revealed that the likelihood of developing type 2 …
Teva conducts boardroom shuffle with four new faces
June 12, 2017Medical Communications, Sales and Marketing
It is well-known that Teva Pharmaceutical has had a rough time of late, particularly in terms of employees. It has …
Sanofi and Regeneron posts positive Praluent cholesterol data
June 12, 2017Research and Development, Sales and Marketing Regeneron, Sanofi, praluent
Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …
AbbVie loses $15 million Depakote birth-defect case
June 12, 2017Sales and Marketing AbbVie, Abbott, Depakote
Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …
High potency drugs – from molecule to market
June 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI
To print or download a PDF version of this article, click here.
Top Ten most read pages on Pharmafile.com this week
June 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten
It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …
Continuous Manufacturing: Novartis’ experiment in the future of drug production
June 9, 2017Manufacturing and Production, Medical Communications Novartis, continuous manufacturing
Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …
Lilly bolsters diabetes assets with $55m KeyBioscience deal
June 9, 2017Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences
Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …
Actelion spin-off hit by blow shortly before buyout
June 9, 2017Medical Communications, Research and Development Actelion, Idorsia, J&J, JJ
Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …
FDA calls for withdrawal of opioid product for first time in history
June 9, 2017Medical Communications Endo pharmaceuticals, FDA, Scott Gottlieb
The FDA, since the appointment of Scott Gottlieb as commissioner, has made strong noises about tackling the opioid crisis and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
